BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10739174)

  • 1. Phenotypes of flavin-containing monooxygenase activity determined by ranitidine N-oxidation are positively correlated with genotypes of linked FM03 gene mutations in a Korean population.
    Kang JH; Chung WG; Lee KH; Park CS; Kang JS; Shin IC; Roh HK; Dong MS; Baek HM; Cha YN
    Pharmacogenetics; 2000 Feb; 10(1):67-78. PubMed ID: 10739174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotyping of flavin-containing monooxygenase using caffeine metabolism and genotyping of FMO3 gene in a Korean population.
    Park CS; Chung WG; Kang JH; Roh HK; Lee KH; Cha YN
    Pharmacogenetics; 1999 Apr; 9(2):155-64. PubMed ID: 10376762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a physiologically based pharmacokinetic model to predict the effects of flavin-containing monooxygenase 3 (FMO3) polymorphisms on itopride exposure.
    Zhou W; Humphries H; Neuhoff S; Gardner I; Masson E; Al-Huniti N; Zhou D
    Biopharm Drug Dispos; 2017 Sep; 38(6):389-393. PubMed ID: 28255999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnic differences in allelic frequency of two flavin-containing monooxygenase 3 (FMO3) polymorphisms: linkage and effects on in vivo and in vitro FMO activities.
    Park CS; Kang JH; Chung WG; Yi HG; Pie JE; Park DK; Hines RN; McCarver DG; Cha YN
    Pharmacogenetics; 2002 Jan; 12(1):77-80. PubMed ID: 11773868
    [No Abstract]   [Full Text] [Related]  

  • 5. Trimethylaminuria (fish odor syndrome): genotype characterization among Portuguese patients.
    Ferreira F; Esteves S; Almeida LS; Gaspar A; da Costa CD; Janeiro P; Bandeira A; Martins E; Teles EL; Garcia P; Azevedo L; Vilarinho L
    Gene; 2013 Sep; 527(1):366-70. PubMed ID: 23791655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human flavin-containing monooxygenase form 3: cDNA expression of the enzymes containing amino acid substitutions observed in individuals with trimethylaminuria.
    Cashman JR; Bi YA; Lin J; Youil R; Knight M; Forrest S; Treacy E
    Chem Res Toxicol; 1997 Aug; 10(8):837-41. PubMed ID: 9282831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel variants and haplotypes of human
    Shimizu M; Yoda H; Igarashi N; Makino M; Tokuyama E; Yamazaki H
    Xenobiotica; 2019 Oct; 49(10):1244-1250. PubMed ID: 30351217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzydamine N-oxidation as an index reaction reflecting FMO activity in human liver microsomes and impact of FMO3 polymorphisms on enzyme activity.
    Störmer E; Roots I; Brockmöller J
    Br J Clin Pharmacol; 2000 Dec; 50(6):553-61. PubMed ID: 11136294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants of flavin-containing monooxygenase 3 (FMO3) in Japanese subjects identified by phenotyping for trimethylaminuria and found in a database of genome resources.
    Shimizu M; Koibuchi N; Mizugaki A; Hishinuma E; Saito S; Hiratsuka M; Yamazaki H
    Drug Metab Pharmacokinet; 2021 Jun; 38():100387. PubMed ID: 33831674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavin monooxygenase 3 (FMO3) polymorphism in a white population: allele frequencies, mutation linkage, and functional effects on clozapine and caffeine metabolism.
    Sachse C; Ruschen S; Dettling M; Schley J; Bauer S; Müller-Oerlinghausen B; Roots I; Brockmöller J
    Clin Pharmacol Ther; 1999 Oct; 66(4):431-8. PubMed ID: 10546928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two new polymorphisms of the FMO3 gene in Caucasian and African-American populations: comparative genetic and functional studies.
    Lattard V; Zhang J; Tran Q; Furnes B; Schlenk D; Cashman JR
    Drug Metab Dispos; 2003 Jul; 31(7):854-60. PubMed ID: 12814961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and Nongenetic Factors Associated with Protein Abundance of Flavin-Containing Monooxygenase 3 in Human Liver.
    Xu M; Bhatt DK; Yeung CK; Claw KG; Chaudhry AS; Gaedigk A; Pearce RE; Broeckel U; Gaedigk R; Nickerson DA; Schuetz E; Rettie AE; Leeder JS; Thummel KE; Prasad B
    J Pharmacol Exp Ther; 2017 Nov; 363(2):265-274. PubMed ID: 28819071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence variations in the flavin-containing mono-oxygenase 3 gene (FMO3) in fish odour syndrome.
    Basarab T; Ashton GH; Menagé HP; McGrath JA
    Br J Dermatol; 1999 Jan; 140(1):164-7. PubMed ID: 10215790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The frequency distribution of flavin-containing monooxygenase 3 mutant alleles in 28 populations from Yunnan].
    Zeng WM; Yang J; Dong YL; Shi H; Gao L; Yang ZL; Lu J; Hao ZJ; Xiao CJ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Aug; 20(4):318-21. PubMed ID: 12903042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation in the flavin-containing monooxygenase 3 gene, FM03, that causes fish-odour syndrome: activity of the mutant enzyme assessed by proton NMR spectroscopy.
    Murphy HC; Dolphin CT; Janmohamed A; Holmes HC; Michelakakis H; Shephard EA; Chalmers RA; Phillips IR; Iles RA
    Pharmacogenetics; 2000 Jul; 10(5):439-51. PubMed ID: 10898113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variants in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population.
    Shimizu M; Kobayashi Y; Hayashi S; Aoki Y; Yamazaki H
    Mol Genet Metab; 2012 Nov; 107(3):330-4. PubMed ID: 22819296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of age and smoking on in vivo CYP1A2, flavin-containing monooxygenase, and xanthine oxidase activities in Koreans: determination by caffeine metabolism.
    Chung WG; Kang JH; Park CS; Cho MH; Cha YN
    Clin Pharmacol Ther; 2000 Mar; 67(3):258-66. PubMed ID: 10741629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidation of ranitidine by isozymes of flavin-containing monooxygenase and cytochrome P450.
    Chung WG; Park CS; Roh HK; Lee WK; Cha YN
    Jpn J Pharmacol; 2000 Oct; 84(2):213-20. PubMed ID: 11128045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of flavin-containing monooxygenase 3 and CYP2C19 genotypes on plasma disposition and adverse effects of voriconazole administered orally in immunocompromised patients.
    Yamada T; Mino Y; Naito T; Kawakami J
    J Infect Chemother; 2019 Dec; 25(12):1019-1025. PubMed ID: 31239195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fishy taint in chicken eggs is associated with a substitution within a conserved motif of the FMO3 gene.
    Honkatukia M; Reese K; Preisinger R; Tuiskula-Haavisto M; Weigend S; Roito J; Mäki-Tanila A; Vilkki J
    Genomics; 2005 Aug; 86(2):225-32. PubMed ID: 15916878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.